MediWound (MDWD) Return on Capital Employed (2016 - 2025)
MediWound (MDWD) recorded quarterly Return on Capital Employed of 39.09% in Q4 2025, up 9.67% quarter-over-quarter from 43.28% in Q3 2025, and up 169.0% on a YoY basis from 14.53% in Q4 2024.
MediWound (MDWD) Return on Capital Employed (2016 - 2025) Analysis & Trends
MediWound's Return on Capital Employed history runs 10 years deep, the most recent figure standing at 39.09% for Q4 2025.
- In Q4 2025, Return on Capital Employed rose 169.0% year-over-year to 39.09%; the TTM figure through Dec 2025 stood at 39.09% (up 169.0% YoY), while the FY2025 annual figure was 46.64%, down 198.0% from the prior year.
- Return on Capital Employed was 39.09% for Q4 2025 at MediWound, up from 43.28% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 19.18% in Q3 2023 to a low of 106.59% in Q1 2022.
- Historically, Return on Capital Employed has averaged 51.35% across 5 years, with a median of 42.4% in 2025.
- The sharpest annual moves came in 2021 and 2023: Return on Capital Employed slumped 6908 bps in 2021, then surged 8021 bps in 2023.
- A 5-year view of Return on Capital Employed shows it stood at 104.54% in 2021, then soared by 71 bps to 30.63% in 2022, then declined by 3 bps to 31.45% in 2023, then decreased by 30 bps to 40.78% in 2024, then gained by 4 bps to 39.09% in 2025.
- The last three Return on Capital Employed figures came in at 39.09% (Q4 2025), 43.28% (Q3 2025), and 56.82% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -107.40% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -50.43% |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -39.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.09% |
| Sep 30, 2025 | -43.28% |
| Jun 30, 2025 | -56.82% |
| Mar 31, 2025 | -42.28% |
| Dec 31, 2024 | -40.78% |
| Sep 30, 2024 | -42.52% |
| Jun 30, 2024 | -40.66% |
| Mar 31, 2024 | -34.84% |
| Dec 31, 2023 | -31.45% |
| Sep 30, 2023 | -19.18% |
| Jun 30, 2023 | -20.11% |
| Mar 31, 2023 | -26.62% |
| Dec 31, 2022 | -30.63% |
| Sep 30, 2022 | -88.35% |
| Jun 30, 2022 | -100.32% |
| Mar 31, 2022 | -106.59% |
| Dec 31, 2021 | -104.54% |
| Sep 30, 2021 | -68.50% |
| Jun 30, 2021 | -47.81% |
| Mar 31, 2021 | -42.63% |